| Application of artificial intelligence for preoperative diagnostic and prognostic prediction in epithelial ovarian cancer based on blood biomarkers E Kawakami, J Tabata, N Yanaihara, T Ishikawa, K Koseki, Y Iida, M Saito, ... Clinical cancer research 25 (10), 3006-3015, 2019 | 157 | 2019 |
| REToma: a cancer subtype with a shared driver oncogene T Kohno, J Tabata, T Nakaoku Carcinogenesis 41 (2), 123-129, 2020 | 50 | 2020 |
| Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma T Seki, N Yanaihara, JS Shapiro, M Saito, J Tabata, R Yokomizo, ... Scientific Reports 11 (1), 7689, 2021 | 19 | 2021 |
| Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway N Yanaihara, Y Yoshino, D Noguchi, J Tabata, M Takenaka, Y Iida, ... Gynecologic Oncology 168, 83-91, 2023 | 7 | 2023 |
| Polypoid endometriosis of the ovary and müllerianosis of pelvic lymph nodes mimicking an ovarian carcinoma with lymph node metastasis Y Iida, J Tabata, T Yorozu, S Kitai, K Ueda, M Saito, N Yanaihara, ... International cancer conference journal 6, 145-148, 2017 | 6 | 2017 |
| A simple method of quantifying chemotherapy‐induced peripheral neuropathy using PainVision PS‐2100® M Saito, S Odajima, R Yokomizo, J Tabata, Y Iida, K Ueda, N Yanaihara, ... Asia‐Pacific Journal of Clinical Oncology 16 (1), 80-85, 2020 | 5 | 2020 |
| Molecular typing guiding treatment and prognosis of endometrial cancer J Tabata, M Takenaka, A Okamoto Gynecology and Obstetrics Clinical Medicine 3 (1), 7-17, 2023 | 4 | 2023 |
| Bevacizumab increases the sensitivity of olaparib to homologous recombination-proficient ovarian cancer by suppressing CRY1 via PI3K/AKT pathway Y Iida, N Yanaihara, Y Yoshino, M Saito, R Saito, J Tabata, A Kawabata, ... Frontiers in Oncology 14, 1302850, 2024 | | 2024 |
| EP169/# 411 Machine learning method for differential diagnosis and prognosis prediction for early-stage uterine sarcoma using preoperative blood biomarker and age Y Shoburu, N Yanaihara, J Tabata, R Nishimura, M Shimazaki, K Oka, ... International Journal of Gynecologic Cancer 33 (Suppl 4), 2023 | | 2023 |
| Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis J Tabata, T Nakaoku, M Araki, R Yoshino, S Kohsaka, A Otsuka, ... Cancer Research 82 (20), 3751-3762, 2022 | | 2022 |
| Development of a drug response model: prediction of RET TKIs sensitivity using MD simulation. K Maruyama, T Nakaoku, J Tabata, S Nukaga, T Kohno CANCER SCIENCE 113, 923-923, 2022 | | 2022 |
| Annotation of variants of unknown significance on RET for precision oncology T Nakaoku, J Tabata, K Maruyama, T Kohno CANCER SCIENCE 113, 368-368, 2022 | | 2022 |
| Identification of novel druggable mutations of RET kinase-Novel activation mode of RET kinase protein J Tabata, T Nakaoku, K Maruyama, S Nukaga, A Ui, T Kohno CANCER SCIENCE 113, 684-684, 2022 | | 2022 |
| The landscape of oncogenic property of diverse RET tyrosine kinase mutations J Tabata, T Nakaoku, T Kohno CANCER SCIENCE 112, 655-655, 2021 | | 2021 |
| Targeting RET-VUS in precision oncology using molecular dynamics simulation T Nakaoku, J Tabata, M Araki, Y Okuno, T Kohno CANCER SCIENCE 112, 654-654, 2021 | | 2021 |
| RETROSPECTIVE STUDY OF DOSE-DENSE PACLITAXEL AND CARBOPLATIN WITH BEVACIZUMAB AS FIRST-LINE CHEMOTHERAPY IN ADVANCED OVARIAN CANCER H Komazaki, K Takahashi, H Tanabe, A Nakajima, Y Mori, J Tabata, ... INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 28, 740-740, 2018 | | 2018 |
| EVALUATION OF RISK FACTORS FOR MASSIVE POSTPARTUM HEMORRHAGE IN PLACENTA PREVIA N Kitamura, M Horiya, S Tsuda, K Oka, S Horikawa, R Ejima, Y Mori, ... PLACENTA 69, E41-E42, 2018 | | 2018 |
| Laparoscopic conservative surgery for massive ovarian edema with torsion K Ueda, J Tabata, N Yanaihara, Y Nagayoshi, A Kawabata, S Onota, ... Gynecology and Minimally Invasive Therapy 5 (2), 91-93, 2016 | | 2016 |
